News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Stonepine Capital Management, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.9% stake in Gamida Cell Ltd. |
| 08/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.8% stake in IO Biotech, Inc. |
| 08/10/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Alimera Sciences, Inc. |
| 06/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.4% stake in Evolus, Inc. |
| 06/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Aytu BioPharma, Inc. |
| 06/09/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.6% stake in Scynexis, Inc. |
| 04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/18/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.3% stake in Third Harmonic Bio, Inc. |
| 12/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/30/2021 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.1% stake in Adma Biologics, Inc. |
| 11/19/2021 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.2% stake in Yumanity Therapeutics, Inc. |
| 07/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/14/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/29/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/01/2021 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.6% stake in Adamas Pharmaceuticals, Inc. |
| 02/05/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/23/2020 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.7% stake in SCYNEXIS, Inc. |
| 09/11/2020 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.9% stake in Interpace Biosciences, Inc. |
| 08/05/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2020 |
SC 13G
| Stonepine Capital Management, LLC reports a 2.7% stake in Interpace Biosciences, Inc. |
| 04/02/2020 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Baudax Bio, Inc. |
| 03/12/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/21/2020 |
SC 13G
| Stonepine Capital Management, LLC reports a 5% stake in Cidara Therapeutics, Inc. |
| 02/11/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/23/2019 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.1% stake in Novelion Therapeutics Inc. |
| 06/19/2019 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.5% stake in Adamas Pharmaceuticals, Inc. |
| 03/18/2019 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Aptevo Therapeutics, Inc. |
| 11/08/2018 |
SC 13G
| Stonepine Capital Management, LLC reports a 9.3% stake in Neos Therapeutics, Inc. |
| 11/02/2018 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.2% stake in Melinta Therapeutics, Inc. |
| 10/25/2018 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.1% stake in Scynexis, Inc. |
| 10/09/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/28/2018 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.5% stake in Catabasis Pharmaceuticals, Inc. |
| 06/15/2018 |
SC 13G
| Stonepine Capital Management, LLC reports a 6.2% stake in Alphatec Holdings, Inc. |
|
|
|